Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (2016 - 2025)

Catalyst Pharmaceuticals' Cash from Investing Activities history spans 15 years, with the latest figure at -$32000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 63.64% year-over-year to -$32000.0; the TTM value through Dec 2025 reached -$58000.0, up 89.57%, while the annual FY2025 figure was -$58000.0, 89.57% up from the prior year.
  • Cash from Investing Activities reached -$32000.0 in Q4 2025 per CPRX's latest filing, down from -$26000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$10000.0 in Q2 2024 to a low of -$162.4 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$21.8 million, with a median of -$165500.0 recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: crashed 70215.91% in 2023, then surged 99.88% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$41000.0 in 2021, then crashed by 221.95% to -$132000.0 in 2022, then crashed by 28928.79% to -$38.3 million in 2023, then skyrocketed by 99.77% to -$88000.0 in 2024, then soared by 63.64% to -$32000.0 in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Cash from Investing Activities are -$32000.0 (Q4 2025), -$26000.0 (Q2 2025), and -$88000.0 (Q4 2024).